Novo Nordisk reports profit rise, progress on US drug permit
The world's top insulin maker, Novo Nordisk, reported rising quarterly profits on Thursday and said studies required to release long-acting insulin Tresiba in the US would be completed sooner than previously thought.
Aug 7, 2014
0
0